Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75
Document › Details

Biocrates Life Sciences AG. (6/18/13). "Press Release: Wulf Fischer-Knuppertz Appointed New CEO of Biocrates Life Sciences AG". Innsbruck.

Organisation Organisation Biocrates Life Sciences AG
  Group Biocrates (Group)
Products Product metabolomics
  Product 2 in vitro diagnostics (IVD)
Persons Person Fischer-Knuppertz, Wulf (CellTool 202001– CEO before Biocrates 201306–201909 + Fisher Scientific + Roche Diagnostics)
  Person 2 Schnegg, Elgar (Biocrates Life Sciences 200806–201306 CEO LEFT 6/13 before Sandoz/Hexal Austria + FMCG)
     


On 1 June 2013, Dr Wulf Fischer-Knuppertz, took over as Chief Executive Officer (CEO) of the internationally operating biotech company BIOCRATES Life Sciences AG. He will from now on be responsible for the company's corporate and strategic management.


For more than 25 years, Dr Fischer-Knuppertz has held various leading positions in the diagnostics and pharmaceutical industries. Most recently, 56-year-old Fischer-Knuppertz, who holds a PhD in veterinary medicine, was General Manager with Fisher Scientific and before that had held leading positions at Roche Diagnostics. In the field of diagnostics, Fischer-Knuppertz brings not only ample experience in General Management, Business Development, and Marketing and Sales but also an in-depth know-how in personalized medicine to the job.

Fischer-Knuppertz enthusiastically commented his appointment: "I am very attracted to BIOCRATES` unique targeted metabolomics platform capabilities. The technology is highly innovative and has a huge commercial potential. I look forward to establishing relationships and innovative collaborations that will showcase this exceptional metabolomics platform and contribute to BIOCRATES` growth and continued success."

The technical and scientific responsibilities within the BIOCRATES Life Sciences AG management team will continue to be fulfilled by Chief Technology Officer Dr Ralph Zahn. The former Chairman of the Board, Elgar Schnegg, will be leaving the company in an atmosphere of excellent mutual understanding on 30 June 2013.


About BIOCRATES

BIOCRATES Life Sciences AG is a leading biotechnology company based in Innsbruck/Austria focused on the development of metabolomics products and in vitro diagnostics (IVDs) for early disease and progression detection in areas such as nephrology, diabetes, oncology, and endocrinology. The company's mass-spectrometry-based, standardized metabolomic kits and IVDs provide unprecedented accuracy, precision, and multiplexing potential that will help revolutionize the way personalized medicine is applied in R&D and diagnostics.

For more information, please go to www.biocrates.com.

   
Record changed: 2016-03-19

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Biocrates (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px




» top